{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:30Z","timestamp":1792788090203,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.msard.2026.107906","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:25:27Z","timestamp":1788452727000},"page":"107906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neonatal anemia after in-utero exposure to natalizumab: A real-world retrospective cohort study"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1747-5244","authenticated-orcid":false,"given":"Thomas","family":"Parsy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia Pereira","family":"Bettiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninon","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmeline","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107906_bib0001","article-title":"Impact of disease-modifying therapies on pregnancy outcomes in multiple sclerosis: a prospective cohort study from the German multiple sclerosis and pregnancy registry","volume":"48","author":"Bast","year":"2025","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.msard.2026.107906_bib0002","series-title":"Natalizumab \u2013 Grossesse","year":"2024"},{"issue":"1","key":"10.1016\/j.msard.2026.107906_bib0003","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12883-016-0674-4","article-title":"Evaluation of pregnancy outcomes from the Tysabri\u00ae (natalizumab) pregnancy exposure registry: a global, observational, follow-up study","volume":"16","author":"Friend","year":"2016","journal-title":"BMC. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107906_bib0004","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/jamaneurol.2025.2550","article-title":"Therapeutic management during pregnancy and relapse risk in women with multiple sclerosis","volume":"82","author":"Gavoille","year":"2025","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2026.107906_bib0005","doi-asserted-by":"crossref","unstructured":"German K.R, Juul S.E. Neonatal anemia. Curr. Pediatr. Rev.. 19(4):388\u2013394. doi:10.2174\/1573396319666221121140627.","DOI":"10.2174\/1573396319666221121140627"},{"issue":"7","key":"10.1016\/j.msard.2026.107906_bib0006","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamaneurol.2014.209","article-title":"Natalizumab use during the third trimester of pregnancy","volume":"71","author":"Haghikia","year":"2014","journal-title":"JAMa Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107906_bib0007","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/cpt.3656","article-title":"Optimizing maternal and fetal antibody exposure and dosing regimens during pregnancy using a physiologically based pharmacokinetic model","volume":"118","author":"Kardouh","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.msard.2026.107906_bib0008","article-title":"Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis","volume":"93","author":"Landi","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.msard.2026.107906_bib0009","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neurol.2025.03.001","article-title":"Trends in the real-world management of patients with active relapsing-remitting multiple sclerosis treated with natalizumab (TYSABRI\u00ae) in France: an analysis of the PMSI database over five years (2019\u20132023)","volume":"181","author":"Le Page","year":"2025","journal-title":"Rev. Neurol. (Paris)"},{"issue":"13","key":"10.1016\/j.msard.2026.107906_bib0010","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1177\/13524585221079598","article-title":"Natalizumab treatment and pregnancy in multiple sclerosis: a reappraisal of maternal and infant outcomes after 6\u2009years","volume":"28","author":"Portaccio","year":"2022","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2026.107906_bib0011","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/jnnp-2023-332804","article-title":"Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy","volume":"95","author":"Thiel","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107906_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101961","article-title":"Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use","volume":"40","author":"Triplett","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2026.107906_bib0013","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/GCO.0000000000000731","article-title":"Pregnancy and multiple sclerosis: an update","volume":"33","author":"Varyt\u0117","year":"2021","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.msard.2026.107906_bib0014","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/vox.13036","article-title":"Neonatal red blood cell transfusion","volume":"116","author":"Villeneuve","year":"2021","journal-title":"Vox. Sang."},{"issue":"24","key":"10.1016\/j.msard.2026.107906_bib0015","doi-asserted-by":"crossref","first-page":"e2989","DOI":"10.1212\/WNL.0000000000012084","article-title":"Natalizumab, Fingolimod, and dimethyl fumarate use and pregnancy-related relapse and disability in women with multiple sclerosis","volume":"96","author":"Yeh","year":"2021","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:25:12Z","timestamp":1792787112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826009417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":15,"alternative-id":["S2211034826009417"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107906","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal anemia after in-utero exposure to natalizumab: A real-world retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107906"}}